CEP
ABMD

Chicago Equity Partners’s Abiomed Inc ABMD Stock Holding History

Chicago Equity Partners’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-13,270
Closed -$3.79M – 996
2019
Q1 		$3.79M Sell
13,270
-1,005
-7% -$334K 0.15% 194
2018
Q4 		$4.64M Sell
14,275
-1,069
-7% -$371K 0.19% 143
2018
Q3 		$6.9M Buy
15,344
+5,045
+49% +$1.99M 0.2% 140
2018
Q2 		$4.21M Buy
10,299
+3,864
+60% +$1.4M 0.13% 232
2018
Q1 		$1.87M Buy
6,435
+4,875
+313% +$1.24M 0.06% 387
2017
Q4 		$292K Hold
1,560
– – 0.01% 682
2017
Q3 		$263K Buy
+1,560
New +$236K 0.01% 706
2016
Q1 		– Sell
-8,915
Closed -$805K – 677
2015
Q4 		$805K Sell
8,915
-9,500
-52% -$806K 0.02% 399
2015
Q3 		$1.71M Buy
+18,415
New +$1.62M 0.05% 276

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Amundi Asset Management US
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Chicago Equity Partners's ABMD Position: Q2 2019 in Review

Chicago Equity Partners sold out of Abiomed Inc (ABMD) in Q2 2019, closing a stake of 13,270 shares — an estimated $3.79M sold.

Chicago Equity Partners first reported a position in ABMD in Q3 2015 and held it in 9 quarters. The position peaked at $6.9M in Q3 2018. 484 funds tracked by Wall St. Rank hold ABMD as of Q2 2019.

  • Chicago Equity Partners reported no remaining Abiomed Inc position as of Q2 2019 after selling out during the quarter.
  • Chicago Equity Partners sold 13,270 Abiomed Inc shares in Q2 2019, an estimated $3.79M.
  • Chicago Equity Partners first reported a position in Abiomed Inc in Q3 2015 and held it in 9 quarters.
  • Chicago Equity Partners's Abiomed Inc position peaked at $6.9M in Q3 2018.
  • 484 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2019.

Based on Chicago Equity Partners's 13F filing for Q2 2019, filed 2 Aug 2019.